A Double-blinded 6-week Prospective Study to Evaluate the Remission Rate According to Dose of Escitalopram (Lexapro) in Patients With Major Depressive Disorder: a Preliminary Study.

Trial Profile

A Double-blinded 6-week Prospective Study to Evaluate the Remission Rate According to Dose of Escitalopram (Lexapro) in Patients With Major Depressive Disorder: a Preliminary Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms LEADERS
  • Most Recent Events

    • 07 Dec 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016, as reported by ClinicalTrials.gov.
    • 07 Dec 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Jun 2016, as reported by ClinicalTrials.gov.
    • 06 Feb 2013 Planned End Date changed from 1 Mar 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top